Attached files
| file | filename |
|---|---|
| EX-4.1 - CERTIFICATE OF DESIGNATIONS - Sanara MedTech Inc. | wndm_ex41.htm |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 11, 2013
Wound Management Technologies, Inc.
(Exact name of registrant as specified in its charter)
| Texas | 0-11808 | 59-2219994 | ||
| (State or other jurisdiction | (Commission File | (IRS Employer | ||
| incorporation) | Number) | Identification No.) |
| 16633 Dallas Parkway, Suite 250, Addison, TX | 75001 | |
| (Address of principal executive offices) | (Zip Code) | |
Registrant’s telephone number, including area code 972-218-0935
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
This Current Report on Form 8-K/A amends and supplements the Current Report on Form 8-K filed on October 15, 2013 (the “Original Filing”), by Wound Management Technologies, Inc. The Original Filing listed as Exhibit 4.1 the Certificate of Designations, Number, Voting Power, Preferences And Rights of Series C Convertible Preferred Stock (the “Certificate”), but the Certificate was not uploaded to the EDGAR system with the Original Filing. The Certificate has been correctly included with this filing, and all items of the Original Filing remain otherwise unchanged.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
| Exhibit No. | Description | |
| 4.1 |
Certificate of Designations, Number, Voting Power, Preferences And Rights of Series C Convertible Preferred Stock
|
|
| 10.1 |
Letter of Intent
|
|
| 10.2 |
Term Loan Agreement
|
|
| 10.3 |
Senior Secured Convertible Promissory Note
|
|
| 10.4 |
Security Agreement
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
WOUND MANAGEMENT TECHNOLOGIES, INC.
|
|||
|
Date: February 6, 2014
|
By:
|
/s/ Deborah J. Hutchinson | |
| Deborah J. Hutchinson | |||
3